3/27/2020 2:04:07 AM
Genentech: FDA Accepts NDA For Xofluza For Treatment Of Influenza In Children
3/24/2020 2:02:21 AM
Roche Initiates Global Phase III Study And Collects Data On Actemra’s Potential Utility In COVID-19 Pneumonia Patients
3/23/2020 9:03:24 AM
Genentech: FDA Approved Clinical Trial For Actemra To Treat
Hospitalized Patients With Severe COVID-19 Pneumonia
3/23/2020 8:06:14 AM
Genentech: Phase III VIALE-A Study Met Its Dual Primary Endpoints Of OS And Composite Complete Remission Rate
3/19/2020 2:01:33 AM
Roche Begis Phase III Clinical Trial Of Actemra/RoActemra In Hospitalised Patients With Severe COVID-19 Pneumonia
3/13/2020 1:47:38 AM
Roche: FDA Issues Emergency Use Authorization For Cobas SARS-CoV-2 Test
3/12/2020 7:16:07 AM
Roche Says European Commission Approved Venclyxto In Combination With Gazyvaro
3/11/2020 2:13:05 AM
Roche Secures FDA Approval For CINtec PLUS Cytology Test